These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 921888)

  • 1. Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Stephens TC; Peacock JH
    Br J Cancer; 1977 Sep; 36(3):313-21. PubMed ID: 921888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
    Stephens TC; Peacock JH
    Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
    Hill RP; Stanley JA
    Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)].
    Zeller WJ; Berger M
    Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism and schedule dependent cytotoxicity of cyclophosphamide and CCNU in experimental cancer chemotherapy.
    Mulder JH; Edelstein MB; Lelieveld P; van Putten IM
    Eur J Cancer (1965); 1978 May; 14(5):537-42. PubMed ID: 648568
    [No Abstract]   [Full Text] [Related]  

  • 6. Response of two mouse tumours to hyperthermia with CCNU or melphalan.
    Joiner MC; Steel GG; Stephens TC
    Br J Cancer; 1982 Jan; 45(1):17-26. PubMed ID: 7059461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by amphotericin B in murine ependymoblastoma.
    Laurent G; Atassi G; Hildebrand J
    Cancer Res; 1976 Nov; 36(11 Pt 1):4069-73. PubMed ID: 975049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
    Siemann DW
    Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nandrolone decanoate on the toxicity and anti-tumour action of CCNU and FU in murine tumours.
    Bibby MC; Double JA; Mughal MA
    Br J Cancer; 1981 Oct; 44(4):572-7. PubMed ID: 7295514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiments on the chemotheraphy of a transplantable glioblastoma in the rat, employing 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    Waldbaur H; Kuschnir H; Engelmann U; Schmidt H; Schmack B
    Acta Neurochir (Wien); 1978; 42(1-2):103-8. PubMed ID: 696438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at the initial stage after tumor transplantation.
    Li XH; Paulus G; Atassi G; Buyssens N
    Am J Pathol; 1984 Jun; 115(3):403-11. PubMed ID: 6731586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
    Stephens TC; Adams K; Peacock JH
    Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of combination chemotherapy by nitroheterocyclics.
    Siemann DW; Allalunis-Turner MJ
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):129-34. PubMed ID: 3391809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of phenobarbital and high doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the treatment of brain tumor-bearing mice.
    Muller PJ; Tator CH; Bloom ML
    Cancer Res; 1983 May; 43(5):2068-71. PubMed ID: 6831437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of RNA synthesis in murine ependymoblastoma by the combination of amphotericin B and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Laurent G; Dewerie-Vanhouche J; Machin D; Hildebrand J
    Cancer Res; 1980 Mar; 40(3):939-42. PubMed ID: 7471107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis.
    Shih WW; Baumhefner RW; Tourtellotte WW; Haskell CM; Korn EL; Fahey JL
    Clin Exp Immunol; 1983 Jul; 53(1):122-32. PubMed ID: 6603303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrosourea combination chemotherapy: 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (methyl-CCNU) and cyclophosphamide.
    Lokich JJ; Skarin AT
    Oncology; 1975; 32(3-4):169-74. PubMed ID: 768852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of amphotericin B on the survival of brain-tumor-bearing mice treated with CCNU.
    Muller PJ; Tator CH
    J Neurosurg; 1978 Oct; 49(4):579-88. PubMed ID: 690687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW; Morrissey S; Wolf K
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.